[go: up one dir, main page]

HN2008001585A - Inhibidores de los canales de iones task-1 y task-3 - Google Patents

Inhibidores de los canales de iones task-1 y task-3

Info

Publication number
HN2008001585A
HN2008001585A HN2008001585A HN2008001585A HN2008001585A HN 2008001585 A HN2008001585 A HN 2008001585A HN 2008001585 A HN2008001585 A HN 2008001585A HN 2008001585 A HN2008001585 A HN 2008001585A HN 2008001585 A HN2008001585 A HN 2008001585A
Authority
HN
Honduras
Prior art keywords
disorders
cancer
respiratory
task
diseases
Prior art date
Application number
HN2008001585A
Other languages
English (en)
Inventor
Brendei Joachim
Goegelein Heinz
Wirth Klaus
Kamm Walter
Original Assignee
Sanofi Aventis Deutschaland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschaland Gmbh filed Critical Sanofi Aventis Deutschaland Gmbh
Publication of HN2008001585A publication Critical patent/HN2008001585A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN INHIBIDOR DE KV1.5 PARA PRODUCIR UN MEDICAMENTO PARA LA TETRAPIA O PROFILAXIS DE TRASTORNOS RESPIRATORIOS RELACIONADOS CON EL SUEÑO, APNEAS DEL SUEÑO CENTRAL Y OBSTRUCTIVAS, SINDROME DE LA RESISTENCIA DE VIAS AEREAS SUPERIORES, RESPIRACION DE CHEYNE STOKES, RONQUIDO, IMPULSO RESPIRATORIO CENTRAL INTERRUMPIDO, MUERTE INFANTIL SUBITA, HIPOXIA Y APNEAS POST-OPERATIVAS, TRASTORNOS RESPITRATORIOS RELACIONADO CON LA MUSCULATURA, TRASTORNOS RESPIRATORIOS TRAS VENTILACION DE LARGO PLAZO, TRASTORNO RESPIRATORIOS ADAPTACION A LA ALTA MONTAÑA, TRASTORNOS PULMONARES AGUDOS Y CRONICOS CON HIPOXIA E HIPERCAPNIA TRASTORNOS NEUROGENERATIVO, DEMENCIA , ENFERMEDADES DE ALZHEMEIR, ENFERMEDADES DE PARKINSON, ENFERMEDADES DE HUNTINGTON TRASTORNOS CANCERIGENOS, CANCER DE MAMA , CANCER DE PULMON, CANCER DE COLON Y CANCER DE PROSTATA
HN2008001585A 2006-04-27 2008-10-24 Inhibidores de los canales de iones task-1 y task-3 HN2008001585A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006019589A DE102006019589A1 (de) 2006-04-27 2006-04-27 Inhibitoren des TASK-1 und Task-3 Ionenkanals

Publications (1)

Publication Number Publication Date
HN2008001585A true HN2008001585A (es) 2011-04-25

Family

ID=38542297

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2008001585A HN2008001585A (es) 2006-04-27 2008-10-24 Inhibidores de los canales de iones task-1 y task-3

Country Status (4)

Country Link
DE (1) DE102006019589A1 (es)
HN (1) HN2008001585A (es)
UA (1) UA98460C2 (es)
ZA (1) ZA200808171B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TN2018000193A1 (en) * 2015-12-10 2019-10-04 Bayer Pharma AG 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6333337B1 (en) * 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
CA2311483A1 (en) * 2000-06-12 2001-12-12 Gregory N Beatch IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF
US6620849B2 (en) * 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
TW200307539A (en) * 2002-02-01 2003-12-16 Bristol Myers Squibb Co Cycloalkyl inhibitors of potassium channel function
AU2004276238B2 (en) * 2003-09-23 2010-10-28 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
CN1856310A (zh) * 2003-09-23 2006-11-01 默克公司 喹唑啉钾通道抑制剂
US7781457B2 (en) * 2003-09-23 2010-08-24 Merck Sharp & Dohme Corp. Isoquinolinone potassium channel inhibitors
AU2004275720B2 (en) * 2003-09-23 2008-04-24 Merck Sharp & Dohme Corp. Isoquinoline potassium channel inhibitors
WO2005034837A2 (en) * 2003-10-08 2005-04-21 Cardiome Pharma Corporation 7H-IMIDAZO [1,2-α] PYRAZIN-8-ONE COMPOUNDS AS ION CHANNEL MODULATORS
AU2005269505B2 (en) * 2004-07-29 2011-06-16 Merck Sharp & Dohme Corp. Potassium channel inhibitors
CA2588517A1 (en) * 2004-12-01 2006-06-08 Devgen N.V. 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family
CN101084209A (zh) * 2004-12-21 2007-12-05 德福根有限公司 具有Kv4离子通道活性的化合物
DE102005028845A1 (de) * 2005-06-22 2006-12-28 Sanofi-Aventis Deutschland Gmbh Substituierte Heterocyclen, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
DE102006019589A1 (de) 2007-10-31
ZA200808171B (en) 2009-10-28
UA98460C2 (ru) 2012-05-25

Similar Documents

Publication Publication Date Title
AR060822A1 (es) Inhibidores de los canales de iones task-1 y task-3
CY1121543T1 (el) Ενωση πυριδυλαμινοοξεικου οξεος
GEP20207104B (en) 2-phenyl-3-(piperazinomethyl)imidazo[1,2-a]pyridine derivatives as blockers of task-1 and task-2 channels, for the treatment of sleep-related breathing disorders
BR112013020798A2 (pt) terapia de combinação do inibidor mtor /jak
PH12019501408A1 (en) Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy
TN2020000021A1 (en) Substituted diazahetero-bicyclic compounds and their use
PL1919450T3 (pl) Kompozycja liposomowa zawierająca lek przeciwhistaminowy i kortykosteroid oraz jej zastosowanie do wytwarzania leku do leczenia nieżytu nosa i chorób spokrewnionych
EP3666273A3 (en) Methods of treating neurological, metabolic, and other disorders using enantiopure deuterium-enriched pioglitazone
ATE542800T1 (de) Kinasehemmer und ihre anwendungsverfahren
PH12019501458A1 (en) Pharmaceutical dosage forms containing task-1 and task-3 channel inhibitors, and the use of same in breathing disorder therapy
NZ595005A (en) Treatment of insulin-resistant disorders
PH12017501882A1 (en) Methods for treating cancer with a stat3 pathway inhibitor and kinase inhibitor
PH12012501917A1 (en) Phenylpyrazole derivatives
HN2008001585A (es) Inhibidores de los canales de iones task-1 y task-3
ZA200901189B (en) Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders
WO2013054345A3 (en) Pharmaceutical combination
PH12021551186A1 (en) Process for producing pharmaceutical dosage forms comprising inhibitors of task-1 and task-3 channels and use thereof for therapy of respiratory disorders
Kim et al. Drug Induced Sleep Endoscopy for Poor-Responder to Uvulopalatopharyngoplasty in Patient with Obstructive Sleep Apnea Patients.
NZ581853A (en) Sulfonyl-quinoline derivatives
WO2008124128A3 (en) Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders
MX2009006212A (es) Utilizacion de nepafenaco o sus derivados para tratamiento de la rosacea, acne, psoriasis y dermatitis atopica.
TH91927A (th) สารยับยั้ง task-1 และ task-3 ไอออนแชนเนล
WO2007047575A3 (en) Pharmacological treatments for sleep-related breathing disorders
BRPI0606756A2 (pt) derivados de n-hidroxiamida e uso do mesmo
UA35600U (ru) Способ лечения хронического обструктивного заболевания легких